pharmainfo.net/rss.xml - Site Info from FyberSearch

Use this tool to learn about websites, specifically the one you just entered.

If you find some aspect of it inappropriate it is not our fault.

If you are the owner of this website: yes we are a real search engine, we do have a real web crawler called FyberSpider and you can block it if you feel the urge.

Is It Cataloged?

We are in the process of updating this tool. Until we are done just use our search results to check the inclusion status of your site.

Visit this website or continue reading for info about this site saved by the FyberSearch web crawler FyberSpider.

Date & Time Cataloged

June 27th, 2008 at 7:53am

Headers

Date: Fri, 27 Jun 2008 12:53:19 GMT
Server: Apache/2.2.8 (Unix) mod_ssl/2.2.8 OpenSSL/0.9.8b
mod_bwlimited/1.4
ETag: "3dfce313175215a57773bd3d4e9c8e9a"
Expires: Sun, 19 Nov 1978 05:00:00
GMT
Cache-Control: must-revalidate
Set-Cookie:
SESS693b557a85cbe0523743554d5057eae8=9d66c6a7c29d0e885afb947b8932766c; expires=Sun, 20 Jul 2008
16:26:39 GMT; path=/; domain=.pharmainfo.net
Last-Modified: Fri, 27 Jun 2008 12:44:16
GMT
Connection: close
Transfer-Encoding: chunked
Content-Type: application/rss+xml;
charset=utf-8

Page Title

Pharmainfo.net - Pharmaceutical Information For You!

Stripped Text Content

This is just a sample of the content found on this website. Please visit the website to read the entire page.

" http://www.pharmainfo.net en http://www.pharmainfo.net/pharma-industry-news/06/27/2008/dako-enters-collaboration-with-bristol-myers-squibb-pharmacodiagnost <p>Dako Enters into Collaboration with Bristol-Myers Squibb for Pharmacodiagnostics (Marketwire)</p> http://www.pharmainfo.net/pharma-industry-news/06/27/2008/dako-enters-collaboration-with-bristol-myers-squibb-pharmacodiagnost#comments Pharma Industry News Fri, 27 Jun 2008 06:00:07 -0400 44073 at http://www.pharmainfo.net http://www.pharmainfo.net/pharma-industry-news/06/27/2008/european-chmp-issues-positive-opinion-cymbalta-treatment-generalised <p>Eli Lilly and Co and Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion supporting the approval of Cymbalta® for the treatment of Generalised Anxiety Disorder .</p> http://www.pharmainfo.net/pharma-industry-news/06/27/2008/european-chmp-issues-positive-opinion-c"
....
read entire page